ARCHIVES

In Brief: Taxol Development Is NCI ‘Emergency Priority’, Dodd To Focus ACS Effort On Breast Screening

This article is from The Cancer Letter archive.

Vol. 16 No. 47 | December 7, 1990

Download PDF Visit The Full Archive

Related Articles

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014

CHOP Gets Concept Approval; DCT Release RFAs for Lung, Colon Drug Discovery Groups

October 24, 1986

FASEB: Focus on Research Funding, Not PR

June 14, 2013

Eppley Probe Could Lead to Tighter Reporting By NIH supported Investigators

June 17, 1977

DCPTC Proceeding With Plans For Intramural Lab

January 30, 1987

ACS Study Finds Low Tar Cigarettes Cause Few Lung Abnormalities

March 2, 1979